| Genetic steroidogenic defects affecting the gonads and adrenals |
2025-01-30 |
Website |
1.5 European CME credits (ECMEC®) |
| Endocrine disruptors and PCOS |
2025-02-19 |
Website |
1.5 European CME credits (ECMEC®) |
| The brain phenotype in PCOS: androgens, anovulation, and gender |
2025-02-06 |
Website |
1.5 European CME credits (ECMEC®) |
| Risk factors for the development of adolescent PCOS |
2025-02-13 |
Website |
1.5 European CME credits (ECMEC®) |
| Neuroendocrine determinants of PCOS |
2025-02-27 |
Website |
1.5 European CME credits (ECMEC®) |
| Hyperandrogenism and Cardiometabolic Risk in Pre and Postmenopausal Women |
2025-03-06 |
Website |
1.5 European CME credits (ECMEC®) |
| Contraception and Polycystic Ovary Syndrome |
2025-03-13 |
Website |
1.5 European CME credits (ECMEC®) |
| Hormonal corrections before natural pregnancy in polycystic ovary syndrome |
2025-03-27 |
Website |
1.5 European CME credits (ECMEC®) |
| Redefining PCOs phenotypes and rationalizing inositol therapy |
2025-04-03 |
Website |
1.5 European CME credits (ECMEC®) |
| Insulin resistance and compensatory hyperinsulinemia in PCOS: from diagnosis to the choice of the integrative approach |
2025-04-10 |
Website |
1.5 European CME credits (ECMEC®) |
| PCOS from womb to menopause: the importance of lifestyle |
2025-04-24 |
Website |
1.5 European CME credits (ECMEC®) |
| Semaglutides on their own or in combination in the management of PCOs |
2025-05-08 |
Website |
1.5 European CME credits (ECMEC®) |
| Infertility treatment of women with PCOS |
2025-05-21 |
Website |
1.5 European CME credits (ECMEC®) |
| Psychosexual impact of PCOS |
2025-05-29 |
Website |
1.5 European CME credits (ECMEC®) |
